{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T19:33:07Z","timestamp":1781551987693,"version":"3.54.5"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,10,15]],"date-time":"2022-10-15T00:00:00Z","timestamp":1665792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,10,15]],"date-time":"2022-10-15T00:00:00Z","timestamp":1665792000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Objective<\/jats:title>\n                <jats:p>To evaluate the feasibility and performance of self-collected vaginal swab samples for HPV screening among women in Lagos, Nigeria.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A cross-sectional study was implemented from March to August 2020 among sexually active women. Study participants provided same-day paired vaginal swab samples. Medic-sampling and poster-directed self-sampling methods were used to collect the two samples per participant. A real-time PCR assay detected HPV 16, HPV 18, other-high-risk (OHR) HPV, and the human \u03b2-globin gene. The self-collected samples\u2019 sensitivity, specificity, and accuracy were determined against the medic-collected samples using the MedCalc Online Diagnostic Calculator.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Of the 213 women aged 16\u2009~\u200963-year-old recruited, 187 (88%) participants had concordant results, while 26 (12%) participants had discordant results. Among the 187 concordant results, 35 (19%) were HPV positive, 150 (80%) participants were HPV negative, and two (1%) were invalid. 18 (69%) out of the 26 discordant samples were invalid. The self-collected sample was invalid for 14 (54%) participants. Two (8%) medic-collected samples were invalid. Compared to the medic-collected sample, the self-collected sample was 89.80% (95% CI: 77.77\u2009~\u200996.60%) sensitive and 98.21% (95% CI: 94.87\u2009~\u200999.63%) specific, with an accuracy of 96.31% (95% CI: 92.87\u2009~\u200998.40%). The mean age for HPV positive and negative participants were 39 and 40, respectively, with an ANOVA <jats:italic>p<\/jats:italic>-value of 0.3932. The stratification of HPV infection by the age group was not statistically significant (<jats:italic>P<\/jats:italic>\u2009&gt;\u20090.05).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>With high accuracy of 96%, self-collected sampling is adequate when tested with real-time PCR and may increase the uptake of HPV testing. Though more self-collected samples were invalid than medic-collected samples, most likely due to poor collection, they could be identified for repeat testing. Future implementation can avoid this error with improved guidance and awareness.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12889-022-14222-5","type":"journal-article","created":{"date-parts":[[2022,10,15]],"date-time":"2022-10-15T05:02:32Z","timestamp":1665810152000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Self-collected versus medic-collected sampling for human papillomavirus testing among women in Lagos, Nigeria: a comparative study"],"prefix":"10.1186","volume":"22","author":[{"given":"Ning","family":"Feng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Ezechi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mabel","family":"Uwandu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bowofoluwa Sharon","family":"Abimbola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace Deborah","family":"Vincent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ifeoma","family":"Idigbe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leona Chika","family":"Okoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Adesina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane","family":"Okwuzu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahaman Ademolu","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith","family":"Sokei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph Ojonugwa","family":"Shaibu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abidemi Esther","family":"Momoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omowunmi","family":"Sowunmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olaoniye Habeebat","family":"Labo-Popoola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"POPGEC Team","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mfon Victoria","family":"Sunday","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janet","family":"Fayemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah Mfon","family":"Udoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayokun","family":"Omidiji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oluwatobi","family":"Ogundepo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor","family":"Ogbolu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Greg","family":"Ohihoin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agatha","family":"David","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Nzeribe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olufemi","family":"Olaleye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-ping","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chika Kingsley","family":"Onwuamah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,10,15]]},"reference":[{"key":"14222_CR1","doi-asserted-by":"publisher","unstructured":"Cunha APA, Belfort IKP, Mendes FPB, Dos Santos GRB, de Lima Costa LH, de Matos Montero P, et al. Human papillomavirus and its association with other sexually transmitted coinfection among sexually active women from the Northeast of Brazil. Interdiscip Perspect Infect Dis. 2020. https:\/\/doi.org\/10.1155\/2020\/8838317.","DOI":"10.1155\/2020\/8838317"},{"key":"14222_CR2","unstructured":"World Health Organization technical guidance and specifications of medical devices for screening and treatment of precancerous lesions in the prevention of cervical cancer. 2020. https:\/\/www.who.int\/medical_devices\/publications\/tech_specs_precancerous_Lesions_cervical_cancer_devices\/en\/. Accessed 21 May 2020."},{"key":"14222_CR3","doi-asserted-by":"publisher","unstructured":"Wakabayashi R, Nakahama Y, Nguyen V, Espinoza JL. The host-microbe interplay in human papillomavirus-induced carcinogenesis. Microorganisms. 2019;2019. https:\/\/doi.org\/10.3390\/microorganisms7070199.","DOI":"10.3390\/microorganisms7070199"},{"key":"14222_CR4","doi-asserted-by":"publisher","unstructured":"Chan CK, Aimagambetova G, Ukybassova T, Kongrtay K, Azizan A. Human papillomavirus infection and cervical cancer: epidemiology, screening, and vaccination-review of current perspectives. J Oncol. 2019. https:\/\/doi.org\/10.1155\/2019\/3257939.","DOI":"10.1155\/2019\/3257939"},{"key":"14222_CR5","doi-asserted-by":"publisher","unstructured":"Wang R, Pan W, Jin L, Huang W, Li Y, Wu D, et al. Human papillomavirus vaccine against cervical cancer: Opportunity and challenge. Cancer Lett. 2020. https:\/\/doi.org\/10.1016\/j.canlet.2019.11.039.","DOI":"10.1016\/j.canlet.2019.11.039"},{"key":"14222_CR6","doi-asserted-by":"publisher","unstructured":"Hull R, Mbele M, Makhafola T, Hicks C, Wang SM, Reis RM, et al. Cervical cancer in low and middle-income countries. Oncol Lett. 2020. https:\/\/doi.org\/10.3892\/ol.2020.11754.","DOI":"10.3892\/ol.2020.11754"},{"key":"14222_CR7","doi-asserted-by":"publisher","unstructured":"Ajenifuja OK, Ikeri NZ, Adeteye OV, Banjo AA. Comparison between self sampling and provider collected samples for Human Papillomavirus (HPV) Deoxyribonucleic acid (DNA) testing in a Nigerian facility. Pan Afr Med J. 2018. https:\/\/doi.org\/10.11604\/pamj.2018.30.110.14321.","DOI":"10.11604\/pamj.2018.30.110.14321"},{"key":"14222_CR8","doi-asserted-by":"publisher","unstructured":"Momenimovahed Z, Salehiniya H. Incidence, mortality and risk factors of cervical cancer in the world. Biomed Res Ther. 2017, 2017. https:\/\/doi.org\/10.15419\/bmrat.v4i12.386.","DOI":"10.15419\/bmrat.v4i12.386"},{"key":"14222_CR9","doi-asserted-by":"publisher","unstructured":"Brisson M, Kim JJ, Canfell K, Drolet M, Gingras G, Burger EA, et al. Impact of HPV vaccination and cervical screening on cervical cancer elimination: a comparative modelling analysis in 78 low-income and lower-middle-income countries. Lancet. 2020. https:\/\/doi.org\/10.1016\/S0140-6736(20)30068-4.","DOI":"10.1016\/S0140-6736(20)30068-4"},{"key":"14222_CR10","doi-asserted-by":"publisher","unstructured":"Yeh PT, Kennedy CE, de Vuyst H, Narasimhan M. Self-sampling for human papillomavirus (HPV) testing: a systematic review and meta-analysis. BMJ Glob Health. 2019. https:\/\/doi.org\/10.1136\/bmjgh-2018-001351.","DOI":"10.1136\/bmjgh-2018-001351"},{"issue":"4","key":"14222_CR11","first-page":"213","volume":"53","author":"KA Durowade","year":"2012","unstructured":"Durowade KA, Osagbemi GK, Salaudeen AG, Musa OI, Akande TM, Babatunde OA, et al. Prevalence and risk factors of cervical cancer among women in an urban community of Kwara State, north-central Nigeria. J Prev Med Hyg. 2012;53(4):213\u20139.","journal-title":"J Prev Med Hyg"},{"issue":"1","key":"14222_CR12","first-page":"105","volume":"6","author":"YT Nejo","year":"2018","unstructured":"Nejo YT, Olaleye DO, Odaibo GN. Prevalence and risk factors for genital human papillomavirus infections among women in Southwest Nigeria. Arch Basic Appl Med. 2018;6(1):105\u201312.","journal-title":"Arch Basic Appl Med"},{"key":"14222_CR13","volume-title":"Comprehensive cervical cancer control: a guide to essential practice \u2013 2nd ed","author":"World Health Organization","year":"2014","unstructured":"World Health Organization. Comprehensive cervical cancer control: a guide to essential practice \u2013 2nd ed; 2014. ISBN 978 92 4 154895 3"},{"issue":"5","key":"14222_CR14","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.currproblcancer.2018.06.003","volume":"42","author":"M Vu","year":"2018","unstructured":"Vu M, Yu J, Awolude OA, et al. et al. Cervical cancer worldwide. Curr Probl Cancer. 2018;42(5):457\u201365.","journal-title":"Curr Probl Cancer"},{"key":"14222_CR15","doi-asserted-by":"publisher","first-page":"77","DOI":"10.3389\/fpubh.2018.00077","volume":"6","author":"S Gupta","year":"2018","unstructured":"Gupta S, Palmer C, Bik EM, et al. Self-Sampling for Human Papillomavirus Testing: Increased Cervical Cancer Screening Participation and Incorporation in International Screening Programs. Front Public Health. 2018;6:77.","journal-title":"Front Public Health"},{"issue":"1","key":"14222_CR16","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s12905-020-01158-4","volume":"21","author":"AK Mulki","year":"2021","unstructured":"Mulki AK, Withers M. Human Papilloma Virus self-sampling performance in low- and middle-income countries. BMC Womens Health. 2021;21(1):12.","journal-title":"BMC Womens Health"},{"key":"14222_CR17","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.bpobgyn.2020.02.008","volume":"65","author":"N Bhatla","year":"2020","unstructured":"Bhatla N, Singhal S. Primary HPV screening for cervical cancer. Best Pract Res Clin Obstet Gynaecol. 2020;65:98\u2013108.","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"14222_CR18","doi-asserted-by":"publisher","unstructured":"Modibbo F, Iregbu KC, Okuma J, Leeman A, Kasius A, Koning MD, et al. Randomised trial evaluating self-sampling for HPV DNA based tests for cervical cancer screening in Nigeria. Infect Agent Cancer. 2017. https:\/\/doi.org\/10.1186\/s13027-017-0123-z.","DOI":"10.1186\/s13027-017-0123-z"},{"key":"14222_CR19","doi-asserted-by":"publisher","unstructured":"Isa MF, Dareng E, Bamisaye P, Jedy-Agba E, Adewole A, Oyeneyin L, et al. Qualitative study of barriers to cervical cancer screening among Nigerian women. BMJ Open. 2016. https:\/\/doi.org\/10.1136\/bmjopen-\u200b2015-\u200b008533.","DOI":"10.1136\/bmjopen-\u200b2015-\u200b008533"},{"key":"14222_CR20","doi-asserted-by":"publisher","unstructured":"Bogale AL, Belay NB, Medhin G, et al. Molecular epidemiology of human papillomavirus among HIV infected women in developing countries: systematic review and meta-analysis. Virol J. 2020;17:179. https:\/\/doi.org\/10.1186\/s12985-\u200b020-\u200b01448-1.","DOI":"10.1186\/s12985-\u200b020-\u200b01448-1"},{"key":"14222_CR21","doi-asserted-by":"publisher","unstructured":"Taku O, Meiring TL, Gustavsson I, Phohlo K, Garcia-Jardon M, Mbulawa ZZA, et al. Acceptability of self-collection for human papillomavirus detection in the Eastern Cape, South Africa. PLoS One. 2020. https:\/\/doi.org\/10.1371\/journal.pone.0241781.","DOI":"10.1371\/journal.pone.0241781"},{"key":"14222_CR22","doi-asserted-by":"publisher","unstructured":"Hermansson RS, Olovsson M, Gustavsson C, Lindstr\u00f6m AK. Elderly women's experiences of self-sampling for HPV testing. BMC Cancer. 2020. https:\/\/doi.org\/10.1186\/s12885-020-06977-0.","DOI":"10.1186\/s12885-020-06977-0"},{"key":"14222_CR23","doi-asserted-by":"publisher","unstructured":"Aarnio R, \u00d6stensson E, Olovsson M, Gustavsson I, Gyllensten U. Cost-effectiveness analysis of repeated self-sampling for HPV testing in primary cervical screening: a randomised study. BMC Cancer. 2020. https:\/\/doi.org\/10.1186\/s12885-020-07085-9.","DOI":"10.1186\/s12885-020-07085-9"},{"key":"14222_CR24","doi-asserted-by":"publisher","unstructured":"Arbyn M, Smith SB, Temin S, Sultana F, Castle P. Collaboration on Self-Sampling and HPV Testing. Detecting cervical precancer and reaching underscreened women by using HPV testing on self samples: updated meta-analyses. BMJ. 2018. https:\/\/doi.org\/10.1136\/bmj.k4823.","DOI":"10.1136\/bmj.k4823"},{"key":"14222_CR25","doi-asserted-by":"publisher","unstructured":"Brandt T, Wubneh SB, Handebo S, Debalkie G, Ayanaw Y, Alemu K, et al. Genital self-sampling for HPV-based cervical cancer screening: a qualitative study of preferences and barriers in rural Ethiopia. BMC Public Health. 2019. https:\/\/doi.org\/10.1186\/s12889-019-7354-4.","DOI":"10.1186\/s12889-019-7354-4"},{"key":"14222_CR26","doi-asserted-by":"publisher","unstructured":"Kohler RE, Elliott T, Monare B, Moshashane N, Ramontshonyana K, Chatterjee P, et al. HPV self-sampling acceptability and preferences among women living with HIV in Botswana. Int J Gynaecol Obstet. 2019. https:\/\/doi.org\/10.1002\/ijgo.12963.","DOI":"10.1002\/ijgo.12963"},{"key":"14222_CR27","doi-asserted-by":"publisher","unstructured":"Desai KT, Ajenifuja KO, Banjo A, Adepiti CA, Novetsky A, Sebag C, et al. Design and feasibility of a novel program of cervical screening in Nigeria: self-sampled HPV testing paired with visual triage. Infect Agent Cancer. 2020. https:\/\/doi.org\/10.1186\/s13027-020-00324-5.","DOI":"10.1186\/s13027-020-00324-5"},{"key":"14222_CR28","doi-asserted-by":"publisher","unstructured":"Bergengren L, Kaliff M, Larsson GL, Karlsson MG, Helenius G. Comparison between professional sampling and self-sampling for HPV-based cervical cancer screening among postmenopausal women. Int J Gynaecol Obstet. 2018. https:\/\/doi.org\/10.1002\/ijgo.12538.","DOI":"10.1002\/ijgo.12538"}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-022-14222-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12889-022-14222-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-022-14222-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,15]],"date-time":"2022-10-15T17:02:38Z","timestamp":1665853358000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpublichealth.biomedcentral.com\/articles\/10.1186\/s12889-022-14222-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,15]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["14222"],"URL":"https:\/\/doi.org\/10.1186\/s12889-022-14222-5","relation":{},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,15]]},"assertion":[{"value":"18 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 September 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted according to the guidelines in the Declaration of Helsinki, and all participants gave their consent. After reviewing, the study conforms to the principles of medical ethics. It was approved by the Institutional Review Board of NIMR (IRB\/20\/008) and the Chinese Center for Disease Control and Prevention (China CDC) (No. 202111).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1922"}}